CPVI Alone Versus. CPVI Plus Electrophysiological Substrate Ablation in the LA During SR for the Treatment of Non-PAF

NAUnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

CPVI

ablate around the pulmonary vein orifice

PROCEDURE

STABLE-SR

homogenization of the low voltage zones and elimination of the complex electrograms from the transitional zones during sinus rhythm

Trial Locations (1)

210000

RECRUITING

The First Affiliated Hospital of Nanjing Medical University, Nanjing

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

First Affiliated Hospital of Zhejiang University

OTHER

collaborator

Fudan University

OTHER

collaborator

First Affiliated Hospital of Wannan Medical College

OTHER

collaborator

The Second Hospital of Hebei Medical University

OTHER

collaborator

General Hospital of Shenyang Military Region

OTHER

collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

Guangdong Provincial People's Hospital

OTHER

collaborator

Zhongda Hospital

OTHER

collaborator

University of Pennsylvania

OTHER

collaborator

Southlake Regional Health Centre

OTHER

collaborator

German Heart Institute

OTHER

collaborator

Asklepios Kliniken Hamburg GmbH

OTHER

collaborator

National University Hospital, Singapore

OTHER

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

collaborator

National Heart Centre Singapore

OTHER

collaborator

Semmelweis University Heart and Vascular Center

OTHER

collaborator

University of Minnesota

OTHER

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT03448562 - CPVI Alone Versus. CPVI Plus Electrophysiological Substrate Ablation in the LA During SR for the Treatment of Non-PAF | Biotech Hunter | Biotech Hunter